Symposium:
164. Vaccines Against Herpesviruses
Friday, October 5, 2018: 2:00 PM-3:15 PM
Room: S 305-314

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss about progress in herpes simplex vaccines
  • discuss about progress in cytomegalovirus vaccines
  • discuss about progress in varicella vaccines

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Vaccinologists

Tracks: Global ID, Pediatric ID, Adult ID


Moderators:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases and Paul Griffiths, MD, DSc, University College London

Presentations:
2:00 PM
2:50 PM
Advances in CMV Vaccines
Mark R. Schleiss, MD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-243-L01-P

Disclosures:

I. Damon, None

P. Griffiths, shire: Scientific Advisor , funds paid to my institution not to me . chimerix: Scientific Advisor , funds paid to my institution not to me . sanofi pasteur: Grant Investigator , funds paid to my institution not to me . genentech: Scientific Advisor , funds paid to my institution not to me .

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.